PTPRR and neoplasm: We report the case of a patient diagnosed with PTPR (grade III) characterized by a <i>PTEN R130Q</i> alteration with chromosome 10 loss that was treated with everolimus pharmacotherapy alone, resulting in an asymptomatic course and tumor regression, a rare yet notable phenomenon not described in the literature so far with potential to alter the management approach to patients with PTPR.